| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |